Thermo Fisher Scientific ... (TMO)
NYSE: TMO
· Real-Time Price · USD
404.41
-1.64 (-0.40%)
At close: May 15, 2025, 3:59 PM
405.75
0.33%
After-hours: May 15, 2025, 07:59 PM EDT
Thermo Fisher Scientific Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Consumables Revenue | 17.59B | 17.6B | 20.62B | 22.61B | 18.53B | 13.11B | 12.58B |
| Consumables Revenue Growth | -0.06% | -14.68% | -8.78% | +22.03% | +41.33% | +4.24% | n/a |
| Instruments Revenue | 7.45B | 7.65B | 7.92B | 7.75B | 6.78B | 6.39B | 6.29B |
| Instruments Revenue Growth | -2.62% | -3.51% | +2.21% | +14.37% | +6.14% | +1.51% | n/a |
| Service Revenue | 17.84B | 17.61B | 16.37B | 8.85B | 6.91B | 6.05B | 5.49B |
| Service Revenue Growth | +1.31% | +7.62% | +84.94% | +28.04% | +14.32% | +10.13% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 29, 2025 | Dec 31, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Dec 31, 2021 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 | Dec 31, 2020 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 31, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 31, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Oct 1, 2016 | Jul 2, 2016 | Apr 2, 2016 | Dec 31, 2015 | Sep 26, 2015 | Jun 27, 2015 | Mar 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.08B | 2.08B | 2.1B | 2.25B | 2.17B | 1.67B | 1.58B | 1.67B | 1.65B | 1.84B | 1.74B | 1.74B | 1.81B | 1.96B | 1.73B | 1.61B | 1.54B | 1.79B | 1.3B | 1.42B | 1.25B | 1.21B | 1.23B | 1.56B | 1.23B | 1.21B | 1.49B | 1.54B | 1.2B | 1.16B | 1.12B | 1.04B | 1.09B | 1.02B | 1.04B | 992.4M | 991.9M | 968.7M | 911.1M | 928.3M | 916M |
| Selling, General, and Administrative Revenue Growth | -0.29% | -0.67% | -6.63% | +3.74% | +29.55% | +5.96% | -5.68% | +1.64% | -10.35% | +5.34% | +0.17% | -3.76% | -7.66% | +13.38% | +7.00% | +4.60% | -13.94% | +37.61% | -8.05% | +13.27% | +3.56% | -1.79% | -21.41% | +27.13% | +1.74% | -18.79% | -3.37% | +28.50% | +3.18% | +3.64% | +8.39% | -4.94% | +7.11% | -2.50% | +5.08% | +0.05% | +2.39% | +6.32% | -1.85% | +1.34% | n/a |
| Research and Development Revenue | 342M | 374M | 346M | 339M | 331M | 327M | 319M | 345M | 346M | 391M | 351M | 365M | 364M | 392M | 351M | 343M | 320M | 376M | 296M | 264M | 245M | 262M | 247M | 246M | 248M | 251M | 240M | 242M | 234M | 233M | 218.1M | 221.6M | 215.4M | 212.6M | 183.3M | 182.4M | 176.5M | 180.3M | 171.6M | 174.6M | 165.8M |
| Research and Development Revenue Growth | -8.56% | +8.09% | +2.06% | +2.42% | +1.22% | +2.51% | -7.54% | -0.29% | -11.51% | +11.40% | -3.84% | +0.27% | -7.14% | +11.68% | +2.33% | +7.19% | -14.89% | +27.03% | +12.12% | +7.76% | -6.49% | +6.07% | +0.41% | -0.81% | -1.20% | +4.58% | -0.83% | +3.42% | +0.43% | +6.83% | -1.58% | +2.88% | +1.32% | +15.98% | +0.49% | +3.34% | -2.11% | +5.07% | -1.72% | +5.31% | n/a |